A Controlled Therapeutic Trial of Various Diets in Ulcerative Colitis

Wright, Ralph; Truelove, S. C.
July 1965
British Medical Journal;7/17/1965, Vol. 2 Issue 5454, p138
Academic Journal
No abstract available.


Related Articles

  • Controlled trial of azathioprine in chronic ulcerative colitis. Kirk, A.P.; Lennard-Jones, J.E. // British Medical Journal (Clinical Research Edition);5/1/1982, Vol. 284 Issue 6325, p1291 

    Evaluates the controlled trial of azathioprine in chronic ulcerative colitis. Infusion of prednisolone on patients; Complication in placebo colectomy; Therapeutic use of azathioprine.

  • Are there any differences in the efficacy and safety of different formulations of oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? Evidence from Cochrane reviews. Balzola, Federico; Cullen, Garret; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2013, Vol. 14 Issue 1, p24 

    The article presents a study that reviews the difference between various formulations of 5-aminosalicylic acid in patients with ulcerative colitis. It describes the method of the study that observes 2925 ulcerative colitis patients using randomized controlled trials. It outlines the findings of...

  • Positive Data Support New Drug Mechanism in Ulcerative Colitis. Sheridan, Cormac // BioWorld International;6/29/2011, Vol. 16 Issue 26, p4 

    The article reports on the new mode of action discovered in the LT-02, the ulcerative colitis treatment from Lipid Therapeutics GmbH during its Phase IIb trial. LT-02 is a controlled-release formulation of phospholipid phosphatidylcholine. Wolfgang Stremmel, founder of Lipid Therapeutics and...

  • Diet Management for Ulcerative Colitis:. Greenstein, Adrian J. // American Journal of Gastroenterology;Feb1974, Vol. 61 Issue 2, p152 

    Reviews the book "Diet Management for Ulcerative Colitis," by Map Hanson.

  • Ulcerative Colitis.  // Current Medical Literature: Gastroenterology;2008, Vol. 27 Issue 3, p87 

    The article discusses several studies on ulcerative Colitis. In "Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis," the authors analyzed factors that might predict which patients are likely to respond to such rescue treatment. In another study...

  • A randomized controlled trial of a humanized Alpha4Beta7 antibody in Ulcerative Colitis (UC). Feagan, Brian; Greenberg, Gordon; Wild, Gary; McDonald, John; Fedorak, Richard; Pare, Pierre; Kishimoto, Kei; Guitterez-Ramos, Jose-Carlos; Krop, Julie; Vandervoort, Margaret // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS248 

    An abstract of the article concerning ulcerative colitis and randomized trial of antibody is presented.

  • OXIS Reports Promising Results for Ulcerative Colitis Trial.  // Biotech Business;Nov99, Vol. 12 Issue 11, p4 

    Deals with announcement made by OXIS Therapeutics Inc. on the results of the Phase IIA clinical trial of its lead compound, BXT-51072, in patients with mild to moderate ulcerative colitis.

  • Diet and ulcerative colitis.  // British Medical Journal;2/2/1980, Vol. 280 Issue 6210, p293 

    Examines the association of low intake of fiber with ulcerative colitis in developing countries. Evidence of significant differences in diet in person with Crohn's disease; Precedence of ulcerative colitis from unusual diet; Susceptability of British diet in the development of the disease.

  • SURGICAL CURE OF ULCERATIVE COLITIS. Boehme, Earl J. // American Journal of Gastroenterology;Jul1960, Vol. 34 Issue 1, p74 

    Discusses the surgical treatments for ulcerative colitis. Reason for a fewer number of patients undergoing surgery for ulcerative colitis; Implication of steroid administration in ulcerative colitis with colonic bleeding; Regimen of treatment with ulcerative colitis patients during remission...

  • Manipulation of Intestinal Microbial Flora for Therapeutic Benefit in Inflammatory Bowel Diseases: Review of Clinical Trials of Probiotics, Prebiotics and Synbiotics. Heilpern, Debra; Szilagyi, Andrew // Reviews on Recent Clinical Trials;Sep2008, Vol. 3 Issue 3, p167 

    Pathogenesis of Inflammatory Bowel Diseases(Ulcerative Colitis, Crohn's disease and Pouchitis) includes an abnormal immunological response to disturbed intestinal microflora. Therapeutic strategies are designed to intervene in these abnormal host microbial communications. A novel approach in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics